Read the full article on The Market Herald here.
- Recce Pharmaceuticals (RCE) has secured a patent from the European regulator covering two of its synthetic anti-infective formulations
- This is the second time Recce has been granted a patent in the Patent Family 3 group after a patent was previously granted by Japan's regulator
- The new patent will cover marketing and manufacturing activities associated with the company's Recce 327 and Recce 529 drug candidates until February 2037
- These drugs aim to stop the rapid spread of bacteria and viruses, respectively
- The new E.U. patent also covers Recces's use of the candidates on viruses like COVID-19, HIV and Ross River Virus
Recce Pharmaceuticals (ASX:RCE) secures patent from E.U. regulator
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
64.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $130.5M | |||
| Open | High | Low | Value | Volume |
| 66.0¢ | 66.0¢ | 64.0¢ | $31.74K | 49.33K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 24674 | 63.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 64.5¢ | 235 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
65.0¢ |
Change
0.000 ( 0.53 %) |
||||
| Open | High | Low | Volume | ||
| 64.5¢ | 65.0¢ | 64.0¢ | 5994 | ||
| Last updated 11.57am 03/05/2024 ? | |||||
| RCE (ASX) Chart |